Evidence map›Paper›PMID 31417643›Full record

ArticleJournal of Cancer2019

Quantitative Proteomic Analysis and Evaluation of the Potential Prognostic Biomarkers in Cholangiocarcinoma.

Zengwei Tang, Yuan Yang, Jinduo Zhang, Wenkang Fu, Yanyan Lin, Gang Su, Yan Li, Wenbo Meng, Xun Li, Xiaodong Xie

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zengwei TangThe First Clinical Medical School of Lanzhou University, Lanzhou 730000, China.
Yuan YangThe First Clinical Medical School of Lanzhou University, Lanzhou 730000, China.
Jinduo ZhangThe First Clinical Medical School of Lanzhou University, Lanzhou 730000, China.
Wenkang FuThe First Clinical Medical School of Lanzhou University, Lanzhou 730000, China.
Yanyan LinDepartment of Special Minimally Invasive Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, China.
Gang SuSchool of Basic Medical Sciences, Institute of Genetics, Lanzhou University, Lanzhou 730000, China.
Yan LiCleveland Clinic, Department of Inflammation and Immunity, Cleveland OHIO 44195, USA.
Wenbo MengThe First Clinical Medical School of Lanzhou University, Lanzhou 730000, China.
Xun LiThe First Clinical Medical School of Lanzhou University, Lanzhou 730000, China.
Xiaodong XieSchool of Basic Medical Sciences, Institute of Genetics, Lanzhou University, Lanzhou 730000, China.
Lanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioinformaricscholangiocarcinomaiTRAQPPP3CAprognosis

Identifiers

PMID31417643
PMCPMC6692627
OpenAlexW2963634650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.